RT Journal Article
SR Electronic
T1 Excess mortality in India from June 2020 to June 2021 during the COVID pandemic: death registration, health facility deaths, and survey data
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.20.21260872
DO 10.1101/2021.07.20.21260872
A1 Deshmukh, Yashwant
A1 Suraweera, Wilson
A1 Tumbe, Chinmay
A1 Bhowmick, Aditi
A1 Sharma, Sankalp
A1 Novosad, Paul
A1 Fu, Sze Hang
A1 Newcombe, Leslie
A1 Gelband, Hellen
A1 Brown, Patrick
A1 Jha, Prabhat
YR 2021
UL http://medrxiv.org/content/early/2021/07/23/2021.07.20.21260872.abstract
AB Background India’s official death totals from the COVID pandemic are widely regarded as under-reports.Methods We quantified all-cause excess mortality in India, comparing deaths during the peak of the first and second COVID waves (Jul-Dec 2020 and April-June 2021) with month wise deaths in 2015-19 from three sources: Civil Registration System (CRS) mortality reports from 15 states or cities with 37% of India’s population; deaths in 0.2 million health facilities; and a representative survey of 0.14 million adults about COVID deaths.Results During the first viral wave, the median excess mortality compared to CRS baseline was 22% and 41%, respectively, in included states and cities, rising to 46% and 85% during the second wave. In settings with 10 or more months of data across the two waves, the median excess mortality was 32% and 37% for states and cities, respectively. Deaths in health facilities showed a 27% excess mortality from July 2020-May 2021, reaching 120% during April-May 2021. The national survey found 3.5% of adults reported a COVID death in their household in April-June 2021, approximately doubling the 3.2% expected overall deaths. The national survey showed 29-32% excess deaths from June 1, 2020 to June 27, 2021, most of which were likely to be COVID. This translates to 3.1-3.4 million COVID deaths (including 2.5-2.8 million during April-June 2021). National extrapolations from health facility and CRS data suggest 2.7-3.3 million deaths during the year.Conclusions India’s COVID death rate may be about 7-8 times higher than the officially reported 290/million population.Competing Interest StatementThe authors have declared no competing interest.Funding StatementSupported by Canadian Institutes of Health Research (FDN 154277 and 20928). The Canada Research Chairs Program funds PJ.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Unity Health Toronto Research Ethics Board (REB 15-231)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data collected for this study will be made available to others online.